Trademark: 90461564
Word
SAJAZIR
Status
Registered
Status Code
700
Status Date
Tuesday, June 13, 2023
Serial Number
90461564
Registration Number
7081259
Registration Date
Tuesday, June 13, 2023
Mark Type
4000
Filing Date
Tuesday, January 12, 2021
Published for Opposition
Tuesday, August 23, 2022

Trademark Owner History
Cycle Pharmaceuticals Ltd. - Original Registrant

Classifications
5 Pharmaceutical agents for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceutical preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceuticals for the treatment of hereditary angioedema all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations, namely, pain relief medications; veterinary preparations for medical treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals; supplements for the treatment of hereditary angioedema; supplements for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; chemical preparations for the medical treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; Drug delivery agents consisting of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceutical preparations, drugs and medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medical drugs for the treatment of rare diseases, in particular for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of hereditary angioedema, medical enzyme preparations in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for veterinary purposes; medicinal preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Medical and veterinary preparations and articles, namely, pre-filled syringes containing a bradykinin B2 receptor antagonist for medical purposes; Pharmaceuticals and natural remedy preparations, for use in the treatment and management of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist; syringes sold filled with a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema
The wording SAJAZIR has no meaning in a foreign language.

Trademark Events
Jun 13, 2023
Notice Of Registration Confirmation Emailed
Jun 13, 2023
Registered-Principal Register
May 9, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
May 8, 2023
Allowed Principal Register - Sou Accepted
May 4, 2023
Statement Of Use Processing Complete
Apr 18, 2023
Use Amendment Filed
May 4, 2023
Case Assigned To Intent To Use Paralegal
Apr 18, 2023
Teas Statement Of Use Received
Oct 18, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 23, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 23, 2022
Published For Opposition
Aug 3, 2022
Notification Of Notice Of Publication E-Mailed
Jul 15, 2022
Approved For Pub - Principal Register
Jul 14, 2022
Teas/Email Correspondence Entered
Jul 14, 2022
Correspondence Received In Law Office
Jul 14, 2022
Teas Request For Reconsideration Received
Feb 1, 2022
Notification Of Final Refusal Emailed
Feb 1, 2022
Final Refusal E-Mailed
Feb 1, 2022
Final Refusal Written
Jan 20, 2022
Teas/Email Correspondence Entered
Jan 20, 2022
Correspondence Received In Law Office
Jan 20, 2022
Teas Response To Office Action Received
Aug 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2021
Teas Change Of Correspondence Received
Aug 5, 2021
Teas Change Of Owner Address Received
Jul 28, 2021
Notification Of Non-Final Action E-Mailed
Jul 28, 2021
Non-Final Action E-Mailed
Jul 28, 2021
Non-Final Action Written
Jul 21, 2021
Assigned To Examiner
Apr 12, 2021
New Application Office Supplied Data Entered
Jan 15, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24